(Q44088489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

1 reference

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Judith Lindner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

M Sinn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

B V Sinn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

J K Striefler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

J M Stieler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

P Lohneis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

S Bischoff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

H Bläker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

U Pelzer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

M Bahra

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

M Dietel

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

B Dörken

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

H Oettle

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

H Riess

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

20 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

1025-1032

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

European cancer mortality predictions for the year 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Tumor-stroma interactions in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Osteonectin influences growth and invasion of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Diverse biological functions of the SPARC family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

The pancreas cancer microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU084

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDU084

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562449%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference